For thirty years, the regulatory framework governing infant formula in the United States remained largely static, a relic of an era before modern biotechnology and globalized supply chains. That inertia ended in March 2025 with the launch of "Operation Stork Speed," a targeted FDA initiative designed to overhaul quality standards and modernize a market that has long been resistant to change.
The push for reform comes at a pivotal moment, as the agency seeks to integrate contemporary nutritional science into its oversight. Among those influencing this new direction is a Brazilian entrepreneur whose efforts have entered the FDA’s agenda, signaling a move toward more sophisticated production methods. The goal is to move past antiquated benchmarks and create a regulatory environment that can accommodate innovation while ensuring systemic safety.
This shift reflects a broader recognition that critical food systems require the same level of regulatory agility as the pharmaceutical sector. By prioritizing the modernization of infant formula, the FDA is not only addressing past supply chain vulnerabilities but also setting the stage for a more resilient and technologically advanced approach to early childhood nutrition.
With reporting from NeoFeed.
Source · NeoFeed
